Skip to main content

Morphine Sulfate Extended-Release Tablets Shortage

Last Updated: August 14, 2025
Status: Current

Products Affected - Description
    • MS Contin oral extended release tablet, Rhodes, 100 mg, bottle, 100 count, NDC 42858-0799-01 - discontinued
    • MS Contin oral extended release tablet, Rhodes, 15 mg, bottle, 100 count, NDC 42858-0515-01
    • MS Contin oral extended release tablet, Rhodes, 200 mg, bottle, 100 count, NDC 42858-0900-01 - discontinued
    • Morphine sulfate oral extended release tablet, Major, 100 mg, unit-dose blister pack, 100 count, NDC 00904-6560-61 - discontinued
    • Morphine sulfate oral extended release tablet, Major, 15 mg, unit-dose blister pack, 100 count, NDC 00904-6557-61 - discontinued
    • Morphine sulfate oral extended release tablet, Major, 30 mg, unit-dose blister pack, 100 count, NDC 00904-6558-61
    • Morphine sulfate oral extended release tablet, Major, 60 mg, unit-dose blister pack, 100 count, NDC 00904-6559-61 - discontinued
    • Morphine sulfate oral extended release tablet, Rhodes, 100 mg, bottle, 100 count, NDC 42858-0804-01
    • Morphine sulfate oral extended release tablet, Rhodes, 60 mg, bottle, 100 count, NDC 42858-0803-01
    • Morphine sulfate oral extended release tablet, Sun Pharma, 100 mg, bottle, 100 count, NDC 63304-0452-01
    • Morphine sulfate oral extended release tablet, Teva, 100 mg, bottle, 100 count, NDC 00228-4323-11
    • Morphine sulfate oral extended release tablet, Teva, 15 mg, bottle, 100 count, NDC 00228-4270-11
    • Morphine sulfate oral extended release tablet, Teva, 200 mg, bottle, 100 count, NDC 00228-4347-11
    • Morphine sulfate oral extended release tablet, Teva, 30 mg, bottle, 100 count, NDC 00228-4271-11
    • Morphine sulfate oral extended release tablet, Teva, 60 mg, bottle, 100 count, NDC 00228-4311-11
Reason for the Shortage
    • Major did not provide a reason for the shortage. Major discontinued morphine sulfate 15 mg, 60 mg, and 100 mg extended-release tablets.
    • Mallinckrodt refuses to provide availability information.
    • Rhodes has morphine sulfate extended-release tablets available. Rhodes discontinued MS Contin 100 mg and 200 mg tablets.
    • Sun did not provide a reason for the shortage.
    • Teva did not provide a reason for the shortage.
Available Products
    • MS Contin oral extended release tablet, Rhodes, 30 mg, bottle, 100 count, NDC 42858-0631-01
    • MS Contin oral extended release tablet, Rhodes, 60 mg, bottle, 100 count, NDC 42858-0760-01
    • Morphine sulfate oral extended release tablet, Rhodes, 15 mg, bottle, 100 count, NDC 42858-0801-01
    • Morphine sulfate oral extended release tablet, Rhodes, 200 mg, bottle, 100 count, NDC 42858-0805-01
    • Morphine sulfate oral extended release tablet, Rhodes, 30 mg, bottle, 100 count, NDC 42858-0802-01
    • Morphine sulfate oral extended release tablet, Sun Pharma, 15 mg, bottle, 100 count, NDC 63304-0450-01
    • Morphine sulfate oral extended release tablet, Sun Pharma, 200 mg, bottle, 100 count, NDC 63304-0453-01
    • Morphine sulfate oral extended release tablet, Sun Pharma, 30 mg, bottle, 100 count, NDC 63304-0451-01
    • Morphine sulfate oral extended release tablet, Sun Pharma, 60 mg, bottle, 100 count, NDC 63304-0758-01

Estimated Resupply Dates

    • Rhodes has morphine sulfate 60 mg extended-release tablets on back order and the company estimates a release date of late-August 2025. The 100 mg extended-release tablets are on back order and the company cannot estimate a release date.
    • Rhodes has MS Contin 15 mg tablets available in limited supply.
    • Sun has morphine sulfate 100 mg extended-release tablets on back order and the company estimates a release date in October 2025.
    • Teva has all morphine sulfate extended-release tablets on back order and the company cannot estimate release dates.

Updated

Updated August 14, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. Created December 12, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer